PIRANTELIS Polpharma

Medicinal product

(Invented) name

PIRANTELIS Polpharma

Active substance (s)

Pirantelis

Strength

250 mg/5 ml

Pharmaceutical form

geriamoji suspensija

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

P02CC01, Pyrantel

Marketing authorisation holder

Zakłady Farmaceutyczne POLPHARMA S.A., Lenkija

Date of authorisation

1995-02-15

Date of renewal

2008-07-31

Documents

1245 PIRANTELIS Polpharma ger susp II PL 2021_05_14.docx

1245_1 Pakuotės lapelis 2021_05_14.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

5 ml suspensijos yra	5 ml
Pirantelis	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
3241	8731	1008731	buteliukas	15 ml N1		Nereceptinis	LT/1/95/1245/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2008-07-31	Perregistruotas
1995-02-15	Registruotas